AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 27(4), 1978, pp. 762-765
Copyright © 1978 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolfe, M. S.
Right arrow Articles by Moede, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolfe, M. S.
Right arrow Articles by Moede, A. L.

Serum Sickness with Furazolidone*

Martin S. Wolfe AND Austin L. Moede{dagger}
Office of Medical Services, Department of State, Washington, D.C. 20520, and American Embassy, Panama City, Panama

Two cases of serum sickness from furazolidone (Furoxona®), prescribed for giardiasis in Latin America, are described. No previous case of serum sickness related to this drug has been reported in the United States. Tartrazine (yellow dye number 5), a component of furazolidone tablets (Furoxona) manufactured in Latin American countries but no longer included in the drug (Furoxone®) in the United States is suggested as a possible cause of serum sickness.

Accepted for publication February 11, 1978.


* Address reprint requests to: Martin S. Wolfe, M.D., Office of Medical Services, Department of State, Washington, D.C. 20520.


{dagger} Presently Regional Medical Officer, American Embassy, Athens, Greece.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American Society of Tropical Medicine and Hygiene.